Sumitomo Mitsui Trust Group’s 10x Genomics TXG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $69.7M | Buy |
6,017,963
+654,597
| +12% | +$7.58M | 0.04% | 370 |
|
|
2025
Q1 | $46.8M | Sell |
5,363,366
-350,118
| -6% | -$3.06M | 0.03% | 458 |
|
|
2024
Q4 | $82M | Sell |
5,713,484
-659,728
| -10% | -$9.47M | 0.06% | 327 |
|
|
2024
Q3 | $144M | Buy |
6,373,212
+230,145
| +4% | +$5.2M | 0.1% | 198 |
|
|
2024
Q2 | $119M | Buy |
6,143,067
+2,521,289
| +70% | +$49M | 0.09% | 218 |
|
|
2024
Q1 | $136M | Buy |
3,621,778
+1,338,248
| +59% | +$50.2M | 0.09% | 224 |
|
|
2023
Q4 | $128M | Buy |
2,283,530
+565,059
| +33% | +$31.6M | 0.09% | 222 |
|
|
2023
Q3 | $70.9M | Sell |
1,718,471
-47,163
| -3% | -$1.95M | 0.06% | 357 |
|
|
2023
Q2 | $98.6M | Sell |
1,765,634
-255,435
| -13% | -$14.3M | 0.08% | 280 |
|
|
2023
Q1 | $113M | Sell |
2,021,069
-156,919
| -7% | -$8.75M | 0.08% | 258 |
|
|
2022
Q4 | $79.4M | Sell |
2,177,988
-29,270
| -1% | -$1.07M | 0.06% | 358 |
|
|
2022
Q3 | $62.9M | Buy |
2,207,258
+793,419
| +56% | +$22.6M | 0.05% | 413 |
|
|
2022
Q2 | $64M | Sell |
1,413,839
-204,514
| -13% | -$9.25M | 0.05% | 418 |
|
|
2022
Q1 | $123M | Buy |
1,618,353
+184,168
| +13% | +$14M | 0.08% | 275 |
|
|
2021
Q4 | $214M | Sell |
1,434,185
-90,020
| -6% | -$13.4M | 0.13% | 175 |
|
|
2021
Q3 | $222M | Sell |
1,524,205
-215,169
| -12% | -$31.3M | 0.14% | 160 |
|
|
2021
Q2 | $341M | Buy |
1,739,374
+518,185
| +42% | +$101M | 0.2% | 114 |
|
|
2021
Q1 | $221M | Buy |
1,221,189
+904,239
| +285% | +$164M | 0.14% | 173 |
|
|
2020
Q4 | $44.9M | Buy |
316,950
+214,682
| +210% | +$30.4M | 0.03% | 569 |
|
|
2020
Q3 | $12.8M | Sell |
102,268
-105,915
| -51% | -$13.2M | 0.01% | 739 |
|
|
2020
Q2 | $18.6M | Buy |
+208,183
| New | +$18.6M | 0.01% | 688 |
|